Joris B W Elbers1,2, Abrahim Al-Mamgani2, Michiel W M van den Brekel1,3, Katarzyna Jóźwiak4, J P de Boer5, Peter J F M Lohuis1,3, Stefan M Willems6, Marcel Verheij2, Charlotte L Zuur1,3. 1. 1 Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. 2. 2 Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. 3. 3 Department of Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 4. 4 Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands. 5. 5 Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. 6. 6 Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract
OBJECTIVE: Most studies that report on salvage surgery after primary radiotherapy for head and neck squamous cell carcinoma (HNSCC) are small and heterogeneous. Subsequently, some relevant questions remain unanswered. We specifically focused on (1) difference in prognosis per tumor subsite, corrected for disease stage, and (2) differences in prognosis after salvage surgery for local, regional, and locoregional recurrences. STUDY DESIGN: Retrospective analysis. SETTING: Single-center study (2000-2016). SUBJECTS AND METHODS: Patients treated with salvage surgery for HNSCC recurrence after (chemo)radiotherapy. RESULTS: In total, 189 patients were included. Five-year overall survival (OS) was 33%, and median OS was 18 (95% confidence interval [CI], 11-26) months. Treatment-related mortality was 2%. Larynx carcinoma was associated with more favorable local (adjusted hazard ratio [HR] = 4.02; 95% CI, 1.46-11.10; P = .007) and locoregional control (adjusted HR = 5.34; 95% CI, 1.83-15.61; P = .002) than pharyngeal carcinoma. American Society of Anesthesiologists (ASA) score (≥3 vs 1-2: adjusted HR = 3.04; 95% CI, 1.17-7.91; P = .023), pT stage (3-4 vs 1-2: adjusted HR = 4.41; 95% CI, 1.65-11.82; P = .003), and salvage surgery for locoregional recurrences (locoregional vs local: adjusted HR = 3.81; 95% CI, 1.13-11.82; P = .021) were independent predictors for disease-free survival (DFS). CONCLUSION: Salvage surgery for larynx carcinoma, regardless of disease stage and other prognostic factors, results in more favorable loco(regional) control but not favorable DFS than pharyngeal carcinoma. The observed difference in DFS between salvage surgery for local and regional recurrences was not significant after correction for confounders. However, survival following salvage surgery for locoregional disease is significantly worse. For this subgroup, we propose to consider T status and comorbidity for clinical decision making, as high pT stage and ASA score are independent predictors for worse DFS.
OBJECTIVE: Most studies that report on salvage surgery after primary radiotherapy for head and neck squamous cell carcinoma (HNSCC) are small and heterogeneous. Subsequently, some relevant questions remain unanswered. We specifically focused on (1) difference in prognosis per tumor subsite, corrected for disease stage, and (2) differences in prognosis after salvage surgery for local, regional, and locoregional recurrences. STUDY DESIGN: Retrospective analysis. SETTING: Single-center study (2000-2016). SUBJECTS AND METHODS: Patients treated with salvage surgery for HNSCC recurrence after (chemo)radiotherapy. RESULTS: In total, 189 patients were included. Five-year overall survival (OS) was 33%, and median OS was 18 (95% confidence interval [CI], 11-26) months. Treatment-related mortality was 2%. Larynx carcinoma was associated with more favorable local (adjusted hazard ratio [HR] = 4.02; 95% CI, 1.46-11.10; P = .007) and locoregional control (adjusted HR = 5.34; 95% CI, 1.83-15.61; P = .002) than pharyngeal carcinoma. American Society of Anesthesiologists (ASA) score (≥3 vs 1-2: adjusted HR = 3.04; 95% CI, 1.17-7.91; P = .023), pT stage (3-4 vs 1-2: adjusted HR = 4.41; 95% CI, 1.65-11.82; P = .003), and salvage surgery for locoregional recurrences (locoregional vs local: adjusted HR = 3.81; 95% CI, 1.13-11.82; P = .021) were independent predictors for disease-free survival (DFS). CONCLUSION: Salvage surgery for larynx carcinoma, regardless of disease stage and other prognostic factors, results in more favorable loco(regional) control but not favorable DFS than pharyngeal carcinoma. The observed difference in DFS between salvage surgery for local and regional recurrences was not significant after correction for confounders. However, survival following salvage surgery for locoregional disease is significantly worse. For this subgroup, we propose to consider T status and comorbidity for clinical decision making, as high pT stage and ASA score are independent predictors for worse DFS.
Entities:
Keywords:
chemoradiation; head and neck squamous cell carcinoma; radiotherapy; salvage surgery
Authors: Donald T Weed; Serena Zilio; Isildinha M Reis; Zoukaa Sargi; Marianne Abouyared; Carmen R Gomez-Fernandez; Francisco J Civantos; Carla P Rodriguez; Paolo Serafini Journal: Front Immunol Date: 2019-05-31 Impact factor: 7.561
Authors: Joris L Vos; Joris B W Elbers; Oscar Krijgsman; Joleen J H Traets; Xiaohang Qiao; Anne M van der Leun; Yoni Lubeck; Iris M Seignette; Laura A Smit; Stefan M Willems; Michiel W M van den Brekel; Richard Dirven; M Baris Karakullukcu; Luc Karssemakers; W Martin C Klop; Peter J F M Lohuis; Willem H Schreuder; Ludi E Smeele; Lilly-Ann van der Velden; I Bing Tan; Suzanne Onderwater; Bas Jasperse; Wouter V Vogel; Abrahim Al-Mamgani; Astrid Keijser; Vincent van der Noort; Annegien Broeks; Erik Hooijberg; Daniel S Peeper; Ton N Schumacher; Christian U Blank; Jan Paul de Boer; John B A G Haanen; Charlotte L Zuur Journal: Nat Commun Date: 2021-12-22 Impact factor: 14.919
Authors: Franco Ionna; Paolo Bossi; Agostino Guida; Andrea Alberti; Paolo Muto; Giovanni Salzano; Alessandro Ottaiano; Fabio Maglitto; Davide Leopardo; Marco De Felice; Francesco Longo; Salvatore Tafuto; Giuseppina Della Vittoria Scarpati; Francesco Perri Journal: Cancers (Basel) Date: 2021-05-14 Impact factor: 6.639